Alliance Pharma (GB:APH) has released an update.
Alliance Pharma PLC has announced its total number of voting rights, revealing a total of 540,565,539 Ordinary Shares as of June 30, 2024. This figure is pertinent for shareholders who need to disclose changes in their shareholding in the company. The company emphasizes its commitment to growth through investment in key brands and potential strategic acquisitions, while maintaining an asset-light strategy by outsourcing manufacturing and logistics.
For further insights into GB:APH stock, check out TipRanks’ Stock Analysis page.
